The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery

References

• Sahu S, Ram J, Bansal R, Pandav SS, Gupta A. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. J Cataract Refract Surg. 2015;41:2043–48. doi:https://doi.org/10.1016/j.jcrs.2015.10.061.
   PubMed Web of Science ®Google Scholar
• Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol. 1997;115:1119–22.
   PubMed Web of Science ®Google Scholar
• Nichols J, Snyder RW. Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol. 1998;9:40–44.
   PubMedGoogle Scholar
• Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55:108–33. doi:https://doi.org/10.1016/j.survophthal.2009.07.005.
   PubMed Web of Science ®Google Scholar
• Waterbury L, Kunysz EA, Beuerman R. Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol. 1987;3:43–54.
   PubMedGoogle Scholar
• Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Topical ocular delivery of NSAIDs. AAPS J. 2008;10:229–41. doi:https://doi.org/10.1208/s12248-008-9024-9.
   PubMed Web of Science ®Google Scholar
• [No Authors listed]. Voltaren Oftabak 1 mg/ml [package insert]. Clermont-Ferrand (FR): Laboratoires Théa.
   Google Scholar
• [No Authors listed]. Yellox 0.9 mg/ml [package insert]. Rocheser (NY, USA): Baush&Lomb.
   Google Scholar
• Giannaccare G, Fresina M, Agnifili L, Versura P. Ocular-surface temperature modification by cataract surgery. J Cataract Refract Surg. 2016;42:983–89. doi:https://doi.org/10.1016/j.jcrs.2016.04.023.
   PubMed Web of Science ®Google Scholar
• Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol. 1993;111:831–36.
   PubMed Web of Science ®Google Scholar
• Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN. Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol. 2005;50:27–47. doi:https://doi.org/10.1016/j.survophthal.2004.10.004.
   PubMed Web of Science ®Google Scholar
• Walters TR, Goldberg DF, Peace JH, Gow JA. Bromfenac ophthalmic solution 0.07% once daily study group. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology. 2014;121:25–33. doi:https://doi.org/10.1016/j.ophtha.2013.07.006.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2012. ISBN 3-900051-07-0. http://www.R-project.org.
   Google Scholar
• Kurz S, Krummenauer F, Gabriel P, Pfeiffer N, Dick HB. Biaxial microincision versus coaxial small-incision clear cornea cataract surgery. Ophthalmology. 2006;113:1818–26. doi:https://doi.org/10.1016/j.ophtha.2006.05.013.
   PubMed Web of Science ®Google Scholar
• Dick HB, Schwenn O, Krummenauer F, Krist R, Pfeiffer N. Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification. Ophthalmology. 2000;107:241–47.
   PubMed Web of Science ®Google Scholar
• Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol. 1992;76:338–431.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47:S203–218.
   PubMed Web of Science ®Google Scholar
• Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol. 2000;84:332–36.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008;146:813–18. doi:https://doi.org/10.1016/j.ajo.2008.06.004.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Keane PA, Singh J, Saihan Z, Kontos A, Pavesio CE. Comparative analysis of anterior chamber flare grading between clinicians with different levels of experience and semi-automated laser flare photometry. Ocul Immunol Inflamm. 2016;24:184–93. doi:https://doi.org/10.3109/09273948.2014.990042.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30:453–64. doi:https://doi.org/10.1007/s10792-009-9310-2.
   PubMedGoogle Scholar
• Duan P, Liu Y, Li J. The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2017;255:639–49. doi:https://doi.org/10.1007/s00417-017-3599-8.
   PubMed Web of Science ®Google Scholar
• Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25:1492–97.
   PubMed Web of Science ®Google Scholar
• Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, Yabe N. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. J Cataract Refract Surg. 2008;34:57–63. doi:https://doi.org/10.1016/j.jcrs.2007.08.030.
   PubMed Web of Science ®Google Scholar
• Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, Formisano D, Fontana L. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome. J Cataract Refract Surg. 2016;42:1119–25. doi:https://doi.org/10.1016/j.jcrs.2016.04.031.
   PubMed Web of Science ®Google Scholar
• Zhu XJ, Wolff D, Zhang KK, He WW, Sun XH, Lu Y, Zhou P. Molecular inflammation in the contralateral eye after cataract surgery in the first eye. Invest Ophthalmol Vis Sci. 2015;56:5566–73. doi:https://doi.org/10.1167/iovs.15-16531.
   PubMed Web of Science ®Google Scholar
• Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634.
   PubMedGoogle Scholar
• Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol. 2012;6:1259–69. doi:https://doi.org/10.2147/OPTH.S31902.
   PubMedGoogle Scholar
• Endo N, Kato S, Haruyama K, Shoji M, Kitano S. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmol. 2010;88:896–900. doi:https://doi.org/10.1111/j.1755-3768.2009.01582.x.
   PubMed Web of Science ®Google Scholar
• Wielders LH, Lambermont VA, Schouten JS, Van Den Biggelaar FJ, Worthy G, Simons RW, Winkens B, Nuijts RMMA. Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol. 2015;160:968–81. doi:https://doi.org/10.1016/j.ajo.2015.07.032.
   PubMed Web of Science ®Google Scholar
• Modjtahedi BS, Paschal JF, Batech M, Luong TQ, Fong DS. Peri-operative topical non-steroidal anti-inflammatory drugs for macular edema prophylaxis following cataract surgery. Am J Ophthalmol. 2017;176:174–82. doi:https://doi.org/10.1016/j.ajo.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim YH, Park YM. The toxicity of nonsteroidal anti-inflammatory eye drops against human corneal epithelial cells in vitro. J Korean Med Sci. 2015;30:1856–64. doi:https://doi.org/10.3346/jkms.2015.30.12.1856.
   PubMed Web of Science ®Google Scholar
• Qu M, Wang Y, Yang L, Zhou Q. Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components. Mol Vis. 2011;17:3147–55.
   PubMed Web of Science ®Google Scholar
• Kawahara A, Utsunomiya T, Kato Y, Takayanagi Y. Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial. Clin Ophthalmol. 2016;10:385–91. doi:https://doi.org/10.2147/OPTH.S101836.
   PubMed Web of Science ®Google Scholar